Journal Information

Most cited

11
Respiratory Syncytial Virus Vaccination Recommendations for Adults Aged 60 Years and Older: The NeumoExperts Prevention Group Position Paper
Esther Redondo, Irene Rivero-Calle, Enrique Mascarós, Daniel Ocaña, Isabel Jimeno, Ángel Gil, Manuel Linares, María Ángeles Onieva-García, ... Federico Martinón-Torres
Arch Bronconeumol. 2024;60:161-70
11
Open Article
10
Comparison of Long-term Response and Remission to Omalizumab and Anti-IL-5/IL-5R Using Different Criteria in a Real-life Cohort of Severe Asthma Patients
Marcela Valverde-Monge, Patricia Sánchez-Carrasco, Diana Betancor, Blanca Barroso, José Manuel Rodrigo-Muñoz, Ignacio Mahillo-Fernández, Ebymar Arismendi, Irina Bobolea, ... Joaquín Sastre
Arch Bronconeumol. 2024;60:23-32
10
Open Article
10
Spanish Consensus on Remission in Asthma (REMAS)
Francisco Javier Álvarez-Gutiérrez, Francisco Casas-Maldonado, Gregorio Soto-Campos, Marina Blanco-Aparicio, Julio Delgado, Alicia Padilla Galo, Santiago Quirce, Vicente Plaza
Arch Bronconeumol. 2024;60:503-9
10
6
Multidisciplinary Management of Patients With Chronic Obstructive Pulmonary Disease and Cardiovascular Disease
Javier de Miguel-Díez, Julio Núñez Villota, Salud Santos Pérez, Nicolás Manito Lorite, Bernardino Alcázar Navarrete, Juan Francisco Delgado Jiménez, Juan José Soler-Cataluña, Domingo Pascual Figal, ... Juan José Gómez Doblas
Arch Bronconeumol. 2024;60:226-37
6
Open Article
5
N-acetylcysteine Treatment in Chronic Obstructive Pulmonary Disease (COPD) and Chronic Bronchitis/Pre-COPD: Distinct Meta-analyses
Alberto Papi, Franco Alfano, Tommaso Bigoni, Lorenzo Mancini, Amal Mawass, Federico Baraldi, Cristina Aljama, Marco Contoli, Marc Miravitlles
Arch Bronconeumol. 2024;60:269-78
5
Highlights

  • Treatment effects on PROs in chronic bronchitis (CB) with/out COPD are scarcely known.

  • N-acetylcysteine (NAC) improve symptoms and/or QoL in studies conducted in CB.

  • NAC reduce exacerbations in studies conducted in subjects with CB.

  • Similarly, NAC reduce exacerbations and improve symptoms and/or QoL in COPD studies.

Open Article
5
Association between occupational exposure and chronic obstructive pulmonary disease and respiratory symptoms in the Spanish population
Eduardo Loeb, Jan-Paul Zock, Marc Miravitlles, Esther Rodríguez, Juan José Soler-Cataluña, Joan B. Soriano, Francisco García-Río, Pilar de Lucas, ... Jaume Ferrer Sancho
Arch Bronconeumol. 2024;60:16-22
5
Open Article
4
A Critical Review on the Role of Probiotics in Lung Cancer Biology and Prognosis
Sumel Ashique, Neeraj Mishra, Ashish Garg, Nitish Kumar, Zuber Khan, Sourav Mohanto, Dinesh Kumar Chellappan, Arshad Farid, Farzad Taghizadeh-Hesary
Arch Bronconeumol. 2024;60 Supl 2:S46-S58
4
3
NRF2 Signaling Pathway in Chemo/Radio/Immuno-Therapy Resistance of Lung Cancer: Looking Beyond the Tip of the Iceberg
Sri Vidya Ramisetti, Tapas Patra, Vinayak Munirathnam, Jyothi Venkat Sainath, Durgadevi Veeraiyan, Akhileshwar Namani
Arch Bronconeumol. 2024;60 Supl 2:S59-S66
3
3
Predicting Response to In-Hospital Pulmonary Rehabilitation in Individuals Recovering From Exacerbations of Chronic Obstructive Pulmonary Disease
Michele Vitacca, Alberto Malovini, Mara Paneroni, Antonio Spanevello, Piero Ceriana, Armando Capelli, Rodolfo Murgia, Nicolino Ambrosino
Arch Bronconeumol. 2024;60:153-60
3
Open Article
3
Improving the Diagnosis and Treatment of Paediatric Bronchiectasis Through Research and Translation
Anne B. Chang, Shyamali C. Dharmage, Julie M. Marchant, Gabrielle B. McCallum, Peter S. Morris, Andre Schultz, Maree Toombs, Danielle F. Wurzel, ... CRE extended group
Arch Bronconeumol. 2024;60:364-73
3
Open Article
Archivos de Bronconeumología

Are you a health professional able to prescribe or dispense drugs?